The complex relationship of serum adiponectin to COPD outcomes
Chest, 02/28/2012Yoon H et al.
Adiponectin is a complex serum biomarker in COPD, which is associated with decreased risk of cardiovascular events but increased risk of respiratory mortality. Because serum adiponectin is not significantly influenced by smoking status, it is a very promising biomarker of cardiovascular outcomes in COPD.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.